Related Experiment Video
Updated: May 23, 2026
07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Enhanced adaptive capacities after brief treatment for depression
Summary
Patients who develop enhanced adaptive capacities (EACs) during depression treatment show greater resilience to stress. Psychotherapy and strong therapeutic alliances foster higher EACs, improving long-term outcomes.
Area of Science:
- Psychiatry
- Clinical Psychology
- Mental Health Research
Background:
- Depression treatment research often focuses on symptom reduction.
- Understanding factors that promote long-term resilience beyond immediate symptom relief is crucial.
- The role of acquired adaptive capacities in moderating stress reactivity in depression is not fully understood.
Purpose of the Study:
- To identify predictors of depressive symptom intensity following brief depression treatment.
- To examine the moderating effect of enhanced adaptive capacities (EACs) on the relationship between stress and depression.
- To investigate treatment-related factors influencing EAC development.
Main Methods:
- Utilized data from the National Institute of Mental Health-sponsored Treatment of Depression Collaborative Research Program.
- Applied multilevel modeling to depression and stress measures collected at termination and 18-month follow-ups.
- Assessed stress reactivity using the slope of depression on stress and measured enhanced adaptive capacities (EACs).
Main Results:
- Patients experiencing high stress showed more intense depressive symptoms, but this was moderated by EACs.
- Higher early EACs correlated with greater resilience to stress.
- Psychotherapy and stronger therapeutic alliances were associated with greater EAC development compared to medication or placebo.
Conclusions:
- Enhanced adaptive capacities (EACs) are a critical factor in resilience to stress for individuals with depression.
- Treatment evaluation should consider the development of adaptive capacities alongside symptom reduction.
- Psychotherapy and therapeutic alliance strength may enhance patient resilience by fostering EACs.
Related Concept Videos
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...